An estimation and comparison of the cost of home phototherapy versus biologics over a 3-year time horizon in patients with moderate-to-severe plaque psoriasis.
The 340B Drug Pricing Program contains several complexities that covered entities are expected to govern and oversee.
Higher drug costs may be attributable to either high initial doses or a dose increase.
Taking advantage of all the value that nonpharmacy organizations have to offer.
Despite the availability of such products, obesity continues to signifi- cantly contribute to morbidity and mortality in the United States.
The underlying purpose of a study presentation that won the Top Poster Award at the 2019 National Association of Specialty Pharmacy Annual Meeting and Expo in Washington, DC, was to assess whether high-touch, clinic-based specialty pharmacy services could positively affect the affordability of self- and provider-administered migraine medications for patients.
A comprehensive approach requires that patients play an active role in determining medication and nonpharmacologic treatments.
Pediatric health care in the retail clinic setting has been a hot-button issue since the walk-in clinic first entered into big-box stores and pharmacy retailers in the early 2000s.
From navigating online classes to adjusting to either cancelled or switched experiential learning rotations, the pandemic has changed the lives of pharmacy students worldwide.
With the groundbreaking advancements in specialty pharmacy, it is important to recognize the uniqueness of these medications and their respective patient populations.
Amgen’s ABP 501 (Amjevita) shows similar efficacy to the reference adalimumab (Humira) in treating rheumatoid arthritis and supported approval of the biosimilar by the FDA.
Presenters at the International Pharmaceutical Federation (FIP) World Congress in Glasgow, Scotland identified the current landscape of Hepatitis C, how pharmacists can position themselves to aid in point of care testing, and ways to better educate patients and providers.
Strategies for controlling use of specialty pharmaceuticals should focus on situations where these agents are used inappropriately and on improvement of the complex billing process.
Belantamab mafodotin-blmf (Blenrep; GlaxoSmithKline) is the first in its class anti-BCMA therapy to gain FDA approval.
There is no one-size-fits-all solution to the problem of medication nonadherence.
Value-based contracts among pharmaceutical manufacturers and payers have not achieved the success levels necessary to drive significant systemic change.
Incremental gains in survival and new targeted agents in the pipeline offer promise.
Pharmacists most frequently become the formal and informal leaders for the specialty pharmacies they work in.
When you think about recent “disruptors” to the consumer marketplace, you can look around your own neighborhood to see the effects of Uber, Airbnb, and even the craft beer movement.
Now, more than ever, is the time that nurses, pharmacists, pharmacy technicians, and physicians can help those who need access to life-saving medicines, and Dispensary of Hope is a resource.